Clinical trial
Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer
NCT07057791
Study timeline
Study start (actual)2026-03-30Date precision: day
Registry last updated2026-08-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Extensive Stage Lung Small Cell Cancerunresolved
Interventions
Sponsors & collaborators
PrECOG, LLC.lead sponsor
Summit Therapeuticscollaborator
Mapped research locations
ChicagoIllinois, United States1PhiladelphiaPennsylvania, United States1BaltimoreMaryland, United States1MiamiFlorida, United States1PittsburghPennsylvania, United States1ColumbusOhio, United States1The BronxNew York, United States1CharlottesvilleVirginia, United States1New BrunswickNew Jersey, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07057791 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.